<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01487213</url>
  </required_header>
  <id_info>
    <org_study_id>WNI1000</org_study_id>
    <nct_id>NCT01487213</nct_id>
  </id_info>
  <brief_title>Routine Follow-up Versus Self-assessment in Medical Abortion</brief_title>
  <official_title>Routine Follow-up Versus Self-assessment of Complete Abortion Following Medical Abortion, Effect on Its Success and Acceptability: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gynmed Clinic Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to optimize the routines for follow-up after medical
      abortion in order to give women more autonomy by reducing the number of consultations
      involved and to reduce the frequency of postabortal curettage.

      This will be achieved by providing means for women for postabortal self-assessment with the
      use of a quantitative urinary hCG test.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of complete abortions</measure>
    <time_frame>Until 3 months post treatment</time_frame>
    <description>The primary objective is thus to demonstrate the non-inferiority of self-assessment of complete abortion following medical abortion compared to routine follow-up in terms of the percentage of women requiring surgical abortion, within a margin of non-inferiority of 5%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postabortion contraception</measure>
    <time_frame>until 12 months post treatment</time_frame>
    <description>The use of contraception and rate of repeat abortion at follow-up questionnaire at one year.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>util 3 months post treatment</time_frame>
    <description>Number of women reporting adverse events and side effects including infections, bleeding, pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">929</enrollment>
  <condition>Medical Abortion</condition>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine follow-up at the clinic 2-3 weeks after the treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Home self test</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home self assessment of complete medical abortion</intervention_name>
    <description>Self assessment of complete abortion using a home semiquantitative U-hCG test. Follow-up out patient review two-three weeks later by qualified practitioner to evaluate success of procedure using the clinic's standard routine. The patient charts will be reviewed after three months in order to control for possible extra visits related to abortion-related complications.</description>
    <arm_group_label>Home self test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women requesting termination of pregnancy by means of mifepristone followed by home
             administration of misoprostol at &lt; /=63 days of gestation, with no contraindication to
             medical abortion and self administration of misoprostol at home, and who have given
             their informed consent will be eligible for study recruitment.

        Exclusion Criteria:

          -  women who do not wish to participate

          -  women who do not want home administration of misoprostol

          -  women who are unable to communicate in Swedish, Norwegian, English, Finnish or German
             and women with symptoms and signs of ectopic pregnancy

          -  minors (i.e. women &lt; 18 years of age) will not be enrolled for the study.

          -  women seeking termination of pregnancy with no sign of a visible intrauterine
             pregnancy (i.e. visible intrauterine yolk sac).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristina Gemzell-Danielsson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GynMed Clinic</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. Obstetrics and Gynaecology,Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine, University of Oslo and Dept. of Gynaecology,</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Obstetrics and Gynecology, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>SE17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Finland</country>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2011</study_first_submitted>
  <study_first_submitted_qc>December 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2011</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Kristina Gemzell Danielsson</investigator_full_name>
    <investigator_title>professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Medical abortion</keyword>
  <keyword>Termination of pregnancy</keyword>
  <keyword>Mifepristone</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Urine hCG</keyword>
  <keyword>Follow Up</keyword>
  <keyword>Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

